4//SEC Filing
SHALLCROSS STEVEN A 4
Accession 0001104659-25-043510
CIK 0000894158other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 4:01 PM ET
Size
6.0 KB
Accession
0001104659-25-043510
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Award
Stock Options (right to buy)
2025-04-29+190,000→ 190,000 totalExercise: $1.41From: 2025-05-01Exp: 2032-04-29→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 36 months.
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001263501
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 4:01 PM ET
- Size
- 6.0 KB